http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Aung Tim (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Intravenous Iron Therapy: Re-administration after Prior Adverse Reaction
Aung Tim,Thein Hla,Aung Sandy Tin,Soe Benjamin Tin Aung,Ohnmar Ei 대한가정의학회 2023 Korean Journal of Family Medicine Vol.44 No.6
Background: Intravenous (IV) iron therapy is performed in community practices and hospitals with modern for-mulations when oral administration becomes impractical. Effective replacement of iron is important for the treat-ment of iron deficiency and anemia. Can IV iron be rechallenged in individuals with a history of adverse reactions? This review is to explore the challenge of this, when clinically indicated.Methods: After performing a literature search, five studies (combined total sample number=1,006) for re-exposure of IV iron to individuals with a history of past reactions were identified, observed, and analyzed. Re-exposure in-cluded reactions ranging from mild to moderate and few cases of severe type.Results: The majority (>80%) of IV iron rechallenges were tolerable, safe, and successful without major serious inci-dents. There were no reports of major reactions (severe hypersensitivity reactions or anaphylaxis) in these re-expo-sures.Conclusion: Re-administration of IV iron therapy in patients with a previous adverse reaction is plausible, with benefit and risk stratification. A rechallenge would depend on the nature and degree of the adverse reaction and use of alternative formulations. Rechallenge to a previous severe hypersensitivity reaction or anaphylaxis with the same product has not been reported in these studies. Evidence on the benefit of premedication use is conflicting and requires further studies.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
